Data: Bitcoin spot ETF saw a net outflow of $1.23 billion last week, the second highest in history
ChainCatcher News, according to SoSoValue data, during last week's trading days (Eastern Time, October 13 to October 17), bitcoin spot ETFs saw a net outflow of $1.23 billion for the week, with none of the twelve ETFs recording a net inflow.
The bitcoin spot ETF with the largest weekly net outflow last week was Grayscale ETF GBTC, with a weekly net outflow of $298 million. The historical total net outflow of GBTC has reached $24.5 billion. The next largest was the ETF ARKB from Ark Invest and 21Shares, with a weekly net outflow of $290 million. The historical total net inflow for ARKB has reached $2.06 billion.
As of press time, the total net asset value of bitcoin spot ETFs is $143.93 billion, and the ETF net asset ratio (market value as a percentage of bitcoin's total market value) has reached 6.75%. The historical cumulative net inflow has reached $61.54 billion.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
